Association of inflammation with worsening HOMA-insulin resistance

K Park1, M Steffes, D-H Lee

  • 1Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 South 2nd Street, Suite 300, Minneapolis, MN 55454, USA.

Diabetologia
|August 15, 2009
PubMed

Insights

C-reactive protein (CRP) is linked to insulin resistance. Even after accounting for obesity, CRP independently predicts current and future insulin resistance, highlighting its role in metabolic health.

Area of Science:

  • Biomedical research
  • Metabolic health
  • Inflammation markers

Background:

  • Low-grade inflammation, indicated by C-reactive protein (CRP), is increasingly recognized as a factor in metabolic dysfunction.
  • Insulin resistance is a key precursor to type 2 diabetes and cardiovascular disease.

Purpose of the Study:

  • To investigate the cross-sectional and longitudinal associations between C-reactive protein (CRP) and insulin resistance.
  • To determine if these associations are independent of obesity and oxidative stress.

Main Methods:

  • Utilized data from the Coronary Artery Risk Development in Young Adults (CARDIA) study (1992-2006).
  • Measured C-reactive protein (CRP) and insulin resistance via homeostasis model assessment (HOMA-IR).
  • Employed cross-sectional and longitudinal (5-year follow-up) analyses, controlling for body fat and oxidative stress markers.

Main Results:

  • A significant positive association was observed between CRP and insulin resistance, both cross-sectionally and longitudinally.
  • The association between CRP and HOMA-IR remained statistically significant after adjusting for body fat and oxidative stress.
  • Higher CRP levels consistently predicted increased HOMA-IR over time, but not vice versa.

Conclusions:

  • C-reactive protein (CRP) is independently associated with concurrent and future insulin resistance.
  • Obesity explains a significant portion of the CRP-insulin resistance link, but does not fully account for it.
  • Findings suggest CRP is a valuable marker for predicting insulin resistance beyond its association with adiposity.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...